Diamyd starts larger trial in type 2 diabetes patients in Sweden
07 oct. 2004 08h21 HE
|
Diamyd Medical
STOCKHOLM, Sweden, Oct. 7, 2004 (PRIMEZONE) -- At the International Diabetes Federation meeting in Los Angeles, USA, it will be announced today that a larger clinical trial with Diamyd will start in...
20MUSD to Diamyd Medical through new stock emission
14 juin 2004 11h15 HE
|
Diamyd Medical
STOCKHOLM, Sweden, June 14, 2004 (PRIMEZONE) -- Diamyd Medical's preferential rights issue in May of up to 2 318 189 B- shares has been oversubscribed by 70%. The Board has therefore decided, in...
Diabetes Therapeutic Diamyd is effective for at least 2 years
10 juin 2004 10h51 HE
|
Diamyd Medical
STOCKHOLM, Sweden, June 10, 2004 (PRIMEZONE) -- 24-month data from Diamyd Medicals (TM) Phase II clinical trial with the diabetes therapeutic Diamyd(TM) were presented today at the American Diabetes...
Diamyd reports increased long-term effect in diabetes pharmaceutical and carries out guaranteed new share issue
05 avr. 2004 05h05 HE
|
Diamyd Medical
STOCKHOLM, Sweden, April 05, 2004 (PRIMEZONE) --* 18-month data from the Phase II studies with Diamyd(TM) for the treatment of autoimmune diabetes shows that the positive effects achieved after six...
Diamyd, Inc., and Diarect AG Settles Dispute
08 déc. 2003 02h35 HE
|
Diamyd Medical
STOCKHOLM, Sweden, Dec. 08, 2003 (PRIMEZONE) -- In a press release of November 27, Diamyd Medical wrote that it "won" a dispute over Diarect, and that the judge had "decided" in favor of Diamyd. As...
Diamyd, Inc. wins dispute with Diarect AG
27 nov. 2003 04h41 HE
|
Diamyd Medical
STOCKHOLM, Sweden, Nov. 27, 2003 (PRIMEZONE) -- Diamyd Medical AB (listed on the Swedish Stock Exchange, O-list) develops a treatment for insulin dependent diabetes, Diamyd(TM). There has been an...
Diamyd increases C-peptide levels in diabetes patients with GAD antibodies
24 nov. 2003 08h14 HE
|
Diamyd Medical
STOCKHOLM, Sweden, Nov. 24, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) is developing the Diamyd(TM) pharmaceutical for insulin dependent diabetes. In the Annual Report for the financial year 02/03,...
Diamyd Medical: GAD2 Gene Therapy Might be used for Treatment of Anorexia
04 nov. 2003 10h52 HE
|
Diamyd Medical
STOCKHOLM, Sweden, Nov. 4, 2003 (PRIMEZONE) -- An international research group, including among other authors Professor Philippe Froguel (Pasteur Institute, Lille, France) and Professor Ake Lernmark...
Parkinson patient treated with GAD gene therapy in New York
22 août 2003 09h50 HE
|
Diamyd Medical
STOCKHOLM, Sweden, August 22, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) informs that Neurologix Inc has treated a first patient suffering from Parkinson's disease using GAD gene therapy. Diamyd...
Diamyd reports successful clinical phase II trial with diabetes vaccine
14 juin 2003 11h07 HE
|
Diamyd Medical
STOCKHOLM, Sweden, June 14, 2003 (PRIMEZONE) -- Diamyd Medical AB, publicly traded on the Stockholm Stock Exchange in Sweden (O-list), today reported a positive outcome from a phase II trial with its...